ClinicalTrials.gov
public full text
Public Domain
Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis
This study will investigate the safety, tolerability and potential for the use of up to three daily doses of 30-40 mg/kg HU (daily) upon hospitalization for painful vaso-occlusive crises .
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Feasibility and preliminary efficacy of the Balance Program to reduce pain-related disability in pediatric sickle cell disease.#427763
- Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises#909249
- Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis#827327
- Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)#1047426
- Emergency Department Acupuncture for Acute Musculoskeletal Pain Management#1059274
Record · ID 875656
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive